EN PL

EMA: Guideline on the requirements for quality documentation concerning biological investigational medicinal products in clinical trials

17.05.2012
This guideline addresses the specific documentation requirements on the biological, chemical and pharmaceutical quality of IMP containing biological / biotechnology derived substances in cases where no \'simplified IMPD\' is submitted.